ישראל - עברית - Ministry of Health

unipharm ltd, israel - clarithromycin - טבליות מצופות - clarithromycin 500 mg - clarithromycin - clarithromycin - karin is indicated in the treatment of infections caused by one or more susceptible organisms. lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. karin is also indicated in skin and soft tissue infections of mild to moderate severity.karin is also indicated in combination with proton pump inhibitor for the eradication of h.pylori in patients with proven duodenal ulcers. treatment of mycobacterium avium complex infection in aids patients

ישראל - עברית - Ministry of Health

dexcel ltd, israel - clarithromycin - קפליות - clarithromycin 250 mg - clarithromycin - clarithromycin - klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. indications include: lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. upper respiratory tract infections, for example, sinusitis and pharyngitis. klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. klaridex is also indicated in combination with proton pump inhibitor for the eradication of h. pylori in patients with proven duodenal ulcer. treatment of mycobacterium avium complex infection in aids patients.

ישראל - עברית - Ministry of Health

megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 500 mg/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi

ישראל - עברית - Ministry of Health

megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 1 g/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - peginterferon alfa 2b 80 mcg / 0.5 ml - powder for solution for injection - interferon alfa-2b - peg- intron is indicated for the treatment of adult patients with histologically proven chronic hepatitis c who have elevated transaminases without liver decompensation and who are positive for serum hcv-rna or anti-hcv including naive patients with clinically stable hiv coinfection. the best way to use peg- intron in this indication is in combination with ribavirin. this combination is indicated in naive patients including patients with clinically stable hiv co-infection and in patients who have failed previous treatment with interferon alpha (pegylated or nonpegylated ) and ribavirin combination therapy or interferon alpha monotherapy. interferon monotherapy including peg-intron is indicated mainly in case of intolerance or contraindication to ribavirin. please refer also to the ribavirin physician's insert when pegintron is to be used in combination with ribavirin.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - peginterferon alfa 2b 100 mcg / 0.5 ml - powder for solution for injection - peginterferon alfa-2b - peg- intron is indicated for the treatment of adult patients with histologically proven chronic hepatitis c who have elevated transaminases without liver decompensation and who are positive for serum hcv-rna or anti-hcv including naive patients with clinically stable hiv coinfection. the best way to use peg- intron in this indication is in combination with ribavirin. this combination is indicated in naive patients including patients with clinically stable hiv co-infection and in patients who have failed previous treatment with interferon alpha (pegylated or nonpegylated ) and ribavirin combination therapy or interferon alpha monotherapy. interferon monotherapy including peg-intron is indicated mainly in case of intolerance or contraindication to ribavirin. please refer also to the ribavirin physician's insert when pegintron is to be used in combination with ribavirin.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - peginterferon alfa 2b 120 mcg / 0.5 ml - powder for solution for injection - peginterferon alfa-2b - peg- intron is indicated for the treatment of adult patients with histologically proven chronic hepatitis c who have elevated transaminases without liver decompensation and who are positive for serum hcv-rna or anti-hcv including naive patients with clinically stable hiv coinfection. the best way to use peg- intron in this indication is in combination with ribavirin. this combination is indicated in naive patients including patients with clinically stable hiv co-infection and in patients who have failed previous treatment with interferon alpha (pegylated or nonpegylated ) and ribavirin combination therapy or interferon alpha monotherapy. interferon monotherapy including peg-intron is indicated mainly in case of intolerance or contraindication to ribavirin. please refer also to the ribavirin physician's insert when pegintron is to be used in combination with ribavirin.

ישראל - עברית - Ministry of Health

padagis israel pharmaceuticals ltd, israel - vigabatrin - טבליות מצופות פילם - vigabatrin 500 mg - vigabatrin - vigabatrin - treatment in combination with other anti epileptic drugs for patients with resistant partial epilepsy with or without secondary generalisation, that is where all other appropriate drug combinations have proven inadeqate or have not been tolerated.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - guaifenesin; pseudoephedrine hydrochloride; triprolidine hydrochlride - סירופ - guaifenesin 100 mg / 5 ml; pseudoephedrine hydrochloride 30 mg / 5 ml; triprolidine hydrochlride 1.25 mg / 5 ml - triprolidine - triprolidine - histafed expectorant is a proven combination for providing an effective antiallergic action, decongestion with an added expectorant effect.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - guaifenesin; pseudoephedrine hydrochloride; triprolidine hydrochlride - סירופ - guaifenesin 100 mg / 5 ml; pseudoephedrine hydrochloride 30 mg / 5 ml; triprolidine hydrochlride 1.25 mg / 5 ml - triprolidine - triprolidine - cold-care is a proven combination for providing an effective antiallergic action, decongestion with an added expectorant effect.